About Prevtec Microbia
Prevtec Microbia is an Agriculture company based in Montreal (Canada) founded in 2003, and was acquired by Elanco in August 2019. Vaccination biological products for livestock are developed and marketed. Prevtec Microbia has raised $12.41 million across 4 funding rounds from investors including Elanco, Victor Valley College and Telesystem. Its focus areas include Food and Agriculture and Livestock Farming.
Company details
Prevtec Microbia was founded in 2003 in Montreal, Canada, and operates in the biotechnology sector. Focus is placed on the development and marketing of vaccines for livestock animals, including the flagship product ColiProtec F4, which targets postweaning diarrhea in swine caused by enterotoxigenic Escherichia coli with F4 attachment factor. This vaccine is noted as the only one licensed in the European Union for active immunization against the condition.
- Headquarters Montreal, Canada
- Stage Acquired
- SectorsAgriculture
- Website prevtecmicrobia.com
- Social LinkedIn
- Acquired by Elanco (Aug 2019)
Funding Insights of Prevtec Microbia
Prevtec Microbia has successfully raised a total of $12.41M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.87 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.41M
- Total Rounds 4
- Last Round Series A — $1.87M
- First Round $3.94M
(Nov 2011)
- Investors Count 8
All 4 funding rounds of Prevtec Microbia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | $1.87M | Series A | – | – | |
| Sep 2015 | $1.89M | Series A | – | – | |
| Mar 2015 | $4.7M | Series A | – | – | |
| Nov 2011 | $3.94M | Series A | – | – |
9 investors in total: 9 institutional.
Investors in Prevtec Microbia
Prevtec Microbia has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Elanco, Victor Valley College and Telesystem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Telesystem is engaged in investment and innovation across sectors. | telesystem.ca | Montreal, Canada | ||
| echocapital.ca | ||||
Canadian tech and energy companies are invested in by Desjardins-Innovatech. | desjardins-innovatech.com | Montreal, Canada | ||
| acces-capital.ca | ||||
Spanish holding overseeing agrofood production, investments, and sustainable business operations. | 1954 | grupofuertes.com | ||
Business guidance for corporate companies and startups | investquebec.com | Quebec City, Canada | ||
Multiple courses and degrees are offered across diversified streams. | 1961 | vvc.edu | United States | |
Provides comprehensive strategy and development services for businesses. | 2002 | trifermed.com | Barcelona, Spain | |
Veterinary food and medicines products are provided for animal health. | 1954 | elanco.com | Greenfield, United States |
Investor details for Prevtec Microbia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Prevtec Microbia
4 dated milestones of Prevtec Microbia across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Prevtec Microbia is founded.
- Funding First funding round of $3.9M.
- Funding Latest funding round, Series A, of $1.9M.
- Exit Acquired by Elanco.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Prevtec Microbia
Prevtec Microbia was founded in 2003 and raised its 1st funding round 8 years after it was founded.
Prevtec Microbia is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Prevtec Microbia is a funded company, having raised a total of $12.41M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3.94M, raised on Nov 2011.
Prevtec Microbia was founded in 2003 in Montreal, Canada, and operates in the biotechnology sector. Focus is placed on the development and marketing of vaccines for livestock animals, including the flagship product ColiProtec F4, which targets postweaning diarrhea in swine caused by enterotoxigenic Escherichia coli with F4 attachment factor. This vaccine is noted as the only one licensed in the European Union for active immunization against the condition.
Prevtec Microbia has 9 investors. Key investors include Elanco, Victor Valley College, Telesystem, Echo Capital, and Grupo Fuertes.
Yes. Prevtec Microbia was acquired by Elanco in August 2019.